EUVIMEDEUVIMED entdecken
Open Access

Convergent Synthesis of the Minimal Macrolide Antibiotic Narbomycin

Quinn Edmondson iD, Cecilia Panfil iD, Jasmine K Keyes, Andrew K Ecker iD, Nicholas S Settineri iD, Ian B Seiple iD

Journal of the American Chemical Society · 2026

DOI: 10.1021/jacs.6c12688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Quinn Edmondson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California94158…. Hauptthemen laut MEDLINE: Macrolides, Anti-Bacterial Agents. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institutes of Health (NIH), Camille and Henry Dreyfus Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrolide antibiotics are a class of structurally diverse polyketides including essential medicines like erythromycin and azithromycin. Structurally minimal macrolides such as narbomycin lack much of the functionality common to other members of the class and exhibit a distinct mode of action wherein they completely inhibit bacterial growth despite only moderate inhibition of global protein synthesis. Unfortunately, lack of availability of these natural products has prevented a thorough investigation of their unusual mechanisms of action. Here we report a 10-step synthesis of narbomycin enabled by a Liebeskind-Srogl fragment coupling, a novel macrolactonization by direct displacement of an Evans auxiliary, and a stereoselective late-stage enone reduction. In addition to accessing the natural product, the route enables access to C8,19-unsaturated variants which could in principle serve as useful precursors for late-stage functionalization by conjugate addition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrolidesAnti-Bacterial AgentsStereoisomerismMolecular Structure

Substanzen

MacrolidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry and Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California94158, United States.
  • Department of Chemistry, The Scripps Research Institute, La Jolla, California92037, United States.
  • Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, California94720, United States.
  • Department of Chemistry, University of California, Berkeley, California94720, United States.

ORCID-Profile: Quinn Edmondson, Cecilia Panfil, Andrew K Ecker, Nicholas S Settineri, Ian B Seiple

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health (NIH)
  • Camille and Henry Dreyfus Foundation

Zitieren

APA

Edmondson, Q., Panfil, C., Keyes, J. K., Ecker, A. K., Settineri, N. S., & Seiple, I. B. (2026). Convergent Synthesis of the Minimal Macrolide Antibiotic Narbomycin. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c12688

Vancouver

Edmondson Q, Panfil C, Keyes JK, Ecker AK, Settineri NS, Seiple IB. Convergent Synthesis of the Minimal Macrolide Antibiotic Narbomycin. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c12688

BibTeX
@article{Edmondson2026,
  author = {Edmondson, Quinn and Panfil, Cecilia and Keyes, Jasmine K and Ecker, Andrew K and Settineri, Nicholas S and Seiple, Ian B},
  title = {Convergent Synthesis of the Minimal Macrolide Antibiotic Narbomycin},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  doi = {10.1021/jacs.6c12688}
}
Kostenlos starten →